All‐In‐One Biomimetic Nanoplatform Based on Hollow Polydopamine Nanoparticles for Synergistically Enhanced Radiotherapy of Colon Cancer

Small 2022, 18, 2107656 DOI: 10.1002/smll.202107656 In the originally published article, an error was presented in Figure 9C. Furthermore, a typo was introduced into the description of the figure in section 2.8. Metabonomics Study. In the Venn diagram where the “Control vs IR” group overlaps with the “Control vs [email protected]@M+IR” group, 71 metabolites were presented instead of 70. This change also slightly adjusts the percentages of the diagram. The updated Figure 9C is presented below. Furthermore, in section 2.8. Metabonomics Study, the sentence “A total of 112 metabolites were identified between the control and IR groups; 416 metabolites were identified between the control and [email protected]@M+IR groups” should be updated to “A total of 416 metabolites were identified between the control and IR groups; 112 metabolites were identified between the control and [email protected]@M+IR groups.” The authors state that the correction does not affect the final results and apologize for any confusion this may have caused.